dsip delta sleep inducing peptide 5mg sleep-inducing (DSIP) Delta Sleep-Inducing Peptide Research Peptide
Description
Identifier NCT06323161
Most of these effects appear to outperform placebo
The METAOD005 12-week murine study used 300 models across five concentration groups plus one control group and reported a statistically significant mean mass reduction in one peptide-exposed group with improved lipid markers, again limited to obese models
Eloralintide is currently in Phase 3 testing and not FDA-approved yet, but early testing suggests it can help people lose an average of about 10% to 20% of body weight
